Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mittal, M. Roth, J. Hänze, A. Scherer, R. T. Schermuly, H. A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany). Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension. Eur Respir J 2006; 28: Suppl. 50, 4649

Member's Comments

No comment yet.

Related content which might interest you: The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 276 Year: 2009 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Role of lysyl oxidases in pathogenesis of pulmonary emphysema Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature Source: Eur Respir J 2007; 30: Suppl. 51, 56s Year: 2007 Combined inhibition of NADPH oxidase and inducible NOS in prevention of ischemia/reperfusion injury of the lung Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Tobacco smoke-induced emphysema and pulmonary hypertension – Role of NADPH oxidase NOX2 Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Chronic hypoxia-induced pulmonary hypertension is linked to a decrease in the soluble epoxide hydrolase Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 551s Year: 2007 Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004 The role of superoxide in hypoxic pulmonary vasoconstriction in chronically hypoxic rat lungs Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004 Role of NADPH oxidases Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020 Year: 2020